Pancreaticoduodenal disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing elective open pancreaticoduodenectomy; No gender limitation, age 18-65 years old; American Society of Anesthesiologists (ASA) Grade I to II; No abnormal coagulation function; Subjects who agree to participate in this study.
Exclusion criteria
Exclusion criteria: Severe disorders of sight and hearing; Unable to cooperate to complete the test; Serious heart, brain, lung, liver and kidney diseases; A history of drug abuse or addiction; Preoperative mental illness and cognitive impairment; History of local anesthetic allergy; Infection at the puncture site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of sufentanil 24 h after operation;postoperative VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| MAP, HR;Intraoperative dosage of propofol and remifentanil;Recovery time from general anesthesia;TNF-a, IL-6, IL-1ß, Cor and ACTH ;Postoperative sleep PSQI score;Postoperative QoR-15 score;Time to get out of bed for the first time after surgery; First exhaust time; Postoperative recovery time for eating and hospital stay;Postoperative adverse reaction; | — |
Countries
China
Contacts
Ningbo Medical Center LiHuiLi Hospital